Pacira BioSciences

Price & Volume

Stats

52W Range	$11.16-$31.67
Market Cap	$1.2B
Shares Short	5M

Financials

Revenue (12 Mos)	$694.9M
Revenue Growth (YoY)	2.8%
Gross Profit (12 Mos)	$439.5M
Diluted EPS	-$1.98

News

Yahoo Finance • 4 hours ago

PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Yahoo Finance • 2 days ago

PCRX Stockholders Should Contact Shareholder Rights Firm Robbins for Information About the Class Action Against Pacira BioSciences, Inc.

Yahoo Finance • 2 days ago

Lowey Dannenberg Notifies Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

Yahoo Finance • 3 days ago

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

About

CEO	Mr. Frank D. Lee
Address	5401 West Kennedy Boulevard, Tampa, FL, United States, 33609
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Full-Time Employees	711